Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : AbbVie Inc
Deal Size : $582.0 million
Deal Type : Collaboration
Details : Anima will use its mRNA Lightning platform to discover novel mRNA biology modulators against the collaboration targets providing AbbVie exclusive rights to license and further develop and commercialize the programs.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : $42.0 million
January 10, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : AbbVie Inc
Deal Size : $582.0 million
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?